For dental implant surgery, Tramadol hydrochloride shows comparable local anesthetic efficacy when compared to Lignocaine hydrochloride.
In a randomized controlled trial, Tramadol hydrochloride provided comparable pain relief, onset and duration of anesthesia when compared to Lignocaine hydrochloride in patients undergoing dental implant procedures. The goal of the study was to assess Tramadol as a potential alternative to Lignocaine for dental restoration procedures. This split-mouth, double-blind study involved 40 patients (mean age 39.35 years, 62.5% male) undergoing maxillary dental implants.
The enrolled volunteers were administered either 5% Tramadol hydrochloride along with adrenaline or 2% Lignocaine hydrochloride along with adrenaline through supraperiosteal infiltration. Investigators recorded visual analog scale (VAS) pain scores, anesthesia onset and duration, and occurrence of adverse effects. In terms of VAS scores, anesthesia onset and duration, no significant differences were noted (Table 1):
Nausea was reported in 2 patients in the Tramadol group and 1 patient in the Lignocaine group. Hence, Tramadol offers a promising alternative for local anesthesia, particularly for those with Lignocaine contraindications. Further studies are recommended to confirm its broader applicability and safety in dental practice.
Journal of Contemporary Dental Practice
Assessing Tramadol Hydrochloride as an Alternative to Lignocaine Hydrochloride in Dental Implant Procedures: A Randomized Trial
Akshita N Parlawar et al.
Comments (0)